David Salazar
ARTICLES BY THIS AUTHOR
- 7/21/2021
Breathe Right debuts ‘Everybody Strip’ campaign
The 30-second spot and campaign focus on the different places consumers can use Breathe Right strips. - 7/21/2021
Aurobindo’s generic Adalat CC gets FDA OK
The market size of the product was $95 million for the 12-month period ended May 2021, according to IQVIA data. - 7/20/2021
Nature’s Truth donates $3.5M worth of vitamins, supplements to 2 charities
Nature’s Truth donated $3.5 million worth of vitamins and supplements to those in need via partnerships with Feed the Hungry and Convoy of Hope. - 7/20/2021
Walmart Wellness Day makes in-person comeback
Walmart Wellness Day will take place on July 24 at more than 4,700 locations nationwide, marking its return as an in-person event for the first time since January 2020. - 7/20/2021
Second Source Rx hires Mangus to lead sales
Vicki Mangus brings more than 30 years of experience in the pharmaceutical industry to her new role as Second Source Rx's vice president of sales. - 7/19/2021
Camber debuts generic Revatio OS
Camber’s sildenafil for oral suspension is indicated to treat pulmonary arterial hypertension or high blood pressure in the lungs. - 7/19/2021
AAM report: Medicare plans lag in adopting new generics
The Association for Accessible Medicines’ latest report found that Medicare Part D plans are slow to add new generics to their formularies and often place them on nongeneric pricing tiers. - 7/19/2021
Lupin intros Kerydin generic
Branded and generic versions of the product had U.S. sales of $53 million for the year ended May 2021, according to IQVIA data. - 7/19/2021
APhA Foundation’s Impact Network members gain access to point-of-care COVID antibody test
The APhA Foundation is partnering with NowDiagnostics to make the company’s AdexusDx COVID-19 antibody test available to Impact Network members. - 7/19/2021
FDA clears Amneal’s generic TobraDex
IQVIA data for the year ended May 2021 showed annual U.S. sales of TobraDex and its generics was $118 million.
